Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,242,422
-$583,594 QoQ
Shares Held
8,954
-17.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
#1,031
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHELSEA COUNSEL CO holds $9,679,558 across 10 Drug Manufacturers - General names. AMGN ranks #2 (33.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,904 | $4,547,078 | |
| 2 | AMGN |
Amgen Inc
This page
|
8,954 | $3,242,422 | |
| 3 | GSK |
GSK plc
|
9,360 | $490,651 | |
| 4 | PFE |
Pfizer Inc
|
20,000 | $481,600 | |
| 5 | LLY |
ELI LILLY & Co
|
351 | $420,999 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,840 | $364,940 | |
| 7 | SNY |
Sanofi
|
1,845 | $78,707 | |
| 8 | ABBV |
AbbVie Inc.
|
114 | $28,686 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,242,422 | 8,954 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,826,016 | 10,874 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,559,168 | 10,874 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $3,089,807 | 10,949 | Shares | Sole | 2025-11-25 | |
| 2025-06-30 | $3,596,783 | 12,882 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $4,055,446 | 13,017 | Shares | Sole | 2025-05-22 | |
| 2024-12-31 | $3,392,750 | 13,017 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $4,232,872 | 13,137 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $4,307,748 | 13,787 | Shares | Sole | 2024-11-21 | |
| 2024-03-31 | $3,874,428 | 13,627 | Shares | Sole | 2024-06-17 | |
| 2023-12-31 | $3,957,970 | 13,742 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $3,882,238 | 14,445 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $3,241,492 | 14,600 | Shares | Sole | 2023-11-22 | |
| 2023-03-31 | $3,500,540 | 14,480 | Shares | Sole | 2023-05-19 | |
| 2022-12-31 | $3,835,857 | 14,605 | Shares | Sole | 2023-02-23 | |
| 2022-09-30 | $3,426,756 | 15,203 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $4,075,518 | 16,751 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $4,114,809 | 17,016 | Shares | Sole | 2022-05-24 | |
| 2021-12-31 | $3,916,952 | 17,411 | Shares | Sole | 2022-05-23 | |
| 2021-09-30 | $3,831,314 | 18,017 | Shares | Sole | 2022-02-10 | |
| 2021-06-30 | $4,451,361 | 18,262 | Shares | Sole | 2022-02-10 | |
| 2021-03-31 | $4,361,638 | 17,530 | Shares | Sole | 2022-02-10 | |
| 2020-12-31 | $4,206,616 | 18,296 | Shares | Sole | 2022-03-08 | |
| 2020-09-30 | $4,527,605 | 17,814 | Shares | Sole | 2022-05-06 | |
| 2020-06-30 | $4,494,075 | 19,054 | Shares | Sole | 2022-05-06 | |
| 2020-03-31 | $3,841,733 | 18,950 | Shares | Sole | 2020-06-12 | |
| No filing history on record for this holder in this stock. | ||||||